The role and significance of HPV testing

HPV testing is a medical method that uses molecular biology technology to detect human papillomavirus (HPV) infection. It is mainly used for cervical cancer screening, infection risk assessment and disease prevention. Its core functions include:Early detection of high-risk HPV infection,Assist in the diagnosis of cervical precancerous lesions,Guide vaccination and follow-up strategies. Test results can help doctors develop personalized management plans to reduce the incidence of cervical cancer. Secondary roles include distinguishing transient from persistent infections and assessing the effectiveness of treatments.

The core value of HPV testing in cervical cancer screening

As a key tool for secondary prevention of cervical cancer, HPV testing canDetect high-risk viral infections earlier than cytology. The World Health Organization (WHO) recommends that women over the age of 30 give priority to HPV testing as a primary screening method because its sensitivity for detecting cervical intraepithelial neoplasia (CIN2+) is as high as 90%. China's "Comprehensive Cervical Cancer Prevention and Control Guidelines" also recommends a combined screening strategy of HPV testing and TCT. Currently, mainstream testing technology can distinguish high-risk subtypes such as 16/18 from other 12 high-risk types, providing accurate basis for clinical intervention.

Application of test results and health management

When the test shows that HPV16/18 is positive, immediate referral for colposcopy is required; for other high-risk types, it is recommended to combine the TCT results to judge. It is worth noting thatAbout 80% of infections will resolve on their own within 1-2 years, but persistent infection requires close monitoring. The American Society for Colposcopy and Cervical Pathology (ASCCP) guidelines emphasize that test results should be comprehensively evaluated in conjunction with the patient's age and immune status. For example, observation and follow-up are usually recommended for women under 30 years old, while those over 30 years old with persistent infection may require more active intervention.

Testing technology and product selection

Mainstream HPV testing products in the market are adoptedNucleic acid hybridization or PCR amplification technology, some of the products certified by the State Food and Drug Administration are as follows:

It should be noted that there are differences in the detection subtype range (14 types/15 types/21 types, etc.) and interpretation standards of different products. When making clinical selection, you should refer to the product instructions and guideline recommendations.

Scientific understanding and comprehensive prevention and control

Although HPV testing is important, it is not the only method. It needs to form a closed loop with vaccination (primary prevention) and regular screening (secondary prevention). Professor Qiao Youlin of the Chinese Academy of Medical Sciences pointed out: "A negative HPV test does not mean lifelong immunity, and a positive test does not mean you have cancer.". It is recommended that women over 21 years old establish regular screening habits and maintain a healthy lifestyle to enhance immunity. Test reports should be interpreted by professional doctors to avoid over-treatment or panic.

Quote sources:
1. WHO "Guidelines for Screening and Treatment of Cervical Precancerous Lesions" (2021)
2. National Health Commission’s “Guidelines for Comprehensive Prevention and Control of Cervical Cancer” (2017)
3. ASCCP "Consensus on Risk-Based Management of Cervical Cancer Screening" (2019)
4. Qiao Youlin et al. "Current Epidemiological Status of HPV and Related Diseases in China" (Chinese Journal of Epidemiology)